(Q35184962)

7 August 2017

1 reference

title

Evolving significance of prognostic markers associated with new treatment strategies in neuroblastoma (English)

1 reference

7 August 2017

Jaume Mora

1

0 references

Nai-Kong V Cheung

series ordinal

3

object named as

Nai-Kong V Cheung

1 reference

7 August 2017

William L Gerald

2

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

197

1 reference

7 August 2017

issue

1-2

1 reference

7 August 2017

page(s)

119-124

1 reference

Genetic heterogeneity and clonal evolution in neuroblastoma.

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900094-6

7 January 2021

Molecular biology of neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900094-6

7 January 2021

Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900094-6

7 January 2021

Pattern of DNA segregation in multipolar anatelophases of different ploidy in euploid and aneuploid mammalian cells cultivated in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900094-6

7 January 2021

N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900094-6

7 January 2021

Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900094-6

7 January 2021

Evolving significance of prognostic markers associated with treatment improvement in patients with stage 4 neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900094-6

7 January 2021

Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900094-6

7 January 2021

Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900094-6

7 January 2021

Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: the St Jude Children's Research Hospital experience, 1962 to 1988

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900094-6

7 January 2021

Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900094-6

7 January 2021

10.1016/S0304-3835(03)00094-6

Identifiers

DOI

1 reference

7 August 2017

1 reference